Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.
Fabiani C, Vitale A, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Capozzoli M, Fusco F, Rana F, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.
Fabiani C, et al. Among authors: capozzoli m.
Clin Rheumatol. 2019 Jan;38(1):63-70. doi: 10.1007/s10067-018-4069-3. Epub 2018 Apr 3.
Clin Rheumatol. 2019.
PMID: 29611087